medRxiv preprint doi: https://doi.org/10.1101/2020.05.17.20104554; this version posted May 24, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Syamantak Khan

Department of Radiation Oncology, Stanford University. drskhan@stanford.edu

The exact risk of dying from COVID-19 has remained elusive and a topic of debate. In this
study, the observed case fatality rates of 46 different countries are hypothesized to be dependent on
their testing rates. An analytical test to this hypothesis suggests that the case fatality rate of COVID19 could be consistent to a certain degree across all countries and states. The current global fatality
rate is estimated to be around 1% and expected to converge between 1-3% when the pandemic ends.
This model can be helpful to estimate the true infection rate for individual countries.

This study uses a mathematical modeling approach to estimate the true outbreak size and clinical severity of COVID-19. It
is a preliminary report that has not been certified yet by peer review. It should not be relied on to guide clinical practice
or health-related behavior and should not be reported in news media as established information.

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2020.05.17.20104554; this version posted May 24, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Syamantak Khan
Department of Radiation Oncology, Stanford University. drskhan@stanford.edu

The exact risk of dying from COVID-19 has remained elusive and a topic of debate. In this study, the observed
case fatality rates of 46 different countries are hypothesized to be dependent on their testing rates. An analytical test to
this hypothesis suggests that the case fatality rate of COVID-19 could be consistent to a certain degree across all countries
and states. The current global fatality rate is estimated to be around 1% and expected to converge between 1-3% when the
pandemic ends. This model can be helpful to estimate the true infection rate for individual countries.

The case fatality rate (CFR) of COVID-19 is defined as the ratio
of reported deaths from SARS-CoV-2 infection to the number
of infected patients. The case fatality of COVID-19 and its
variation across different countries remains debatable (1-4).
In many countries, the case fatality even varies widely across
different states (5). The observed inconsistency of CFR has
been associated with age(3), co-morbidity(6), the efficiency of
the healthcare system(7), three different viral strains(8),
regional weather(9), and even vaccination schedule(10).
However, none of these parameters are probably sufficient to
explain the variation with mathematical precision.
To accurately calculate the fatality rate, it is necessary to
correctly estimate the number of people infected by the virus,
i.e., the denominator of the CFR ratio. (2). But, a salient
feature of COVID-19 disease is its mild and asymptomatic
nature in a large number of infected patients, who can carry
and spread the infection to other healthy susceptible
individuals. Data from recent studies suggest 25%-70%
carriers of SARS-CoV-2 can be asymptomatic or show very
limited symptoms (11, 12). Therefore, the efficiency of COVID19 detection or testing is critical. Accurate detection not only
helps isolate the infected patients, but it also allows accurate
documentation of the infection and fatality rate. However, the
testing infrastructure and policies also widely vary across
nations, once again giving rise to an inconsistency in the
fatality rate. This letter is intended to illustrate an intriguing
relationship between the case fatality and testing rate which
is gradually emerging from the COVID-19 dataset worldwide.
A mathematical correlation function was derived using a
simple model of infection transmission.
As only a very small percent of infected people develop severe
symptoms, the large number of mild and asymptomatic
patients can be missed easily. To overcome this challenge, the
detection strategies (Covid-19 testing) follow an efficient
algorithm. The probability of infection transmission from one
particular individual gradually decreased from the closecontacts (persons who are close, or came close to the infected
individual) to the far-contacts (persons who were physically
distant from the infected individual). The probability of the
spread of the infection approaches to zero for someone who is
located at a large distance from the infected individual.
Therefore the detection of COVID-19 infection is largely

performed by a contact tracing method, mostly to maximize
the efficiency of detection. In this method, when a patient
(symptomatic or asymptomatic) is tested positive, all the
individuals who came in close contact with that person in the
last 10-14 days are tested with the highest priority. Thus, the
detection algorithm is optimized by adapting the same
pattern of the infection-transmission (see supplementary note
Q1).
It is fundamentally important to accurately model the true
detection efficiency in a population to know the true outbreak
size and subsequently develop more efficient testing
strategies. The chance of the contracting infection from one
infected person can be mathematically modeled with a
probability distribution function, which gradually decreases
from the close-contacts to the far-contacts. As the spread of
infection occurs continuously and independently at a constant
average rate, the probability distribution is assumed to be
exponentially decaying from close-contacts to far-contacts
according to the following equation (Figure 1):
ğ‘ƒ(ğ‘›) = ğ‘’ âˆ’ğœ†ğ‘›

(1);

where ğ‘ƒ(ğ‘›) is the probability of contracting the infection for
ğ‘›ğ‘¡â„ contact person and ğœ† is a constant representing the rate of
decay. The physical distance of a contact person from the
infected individual increases equivalently with the numerical
value of ğ‘›. The unit cell (or the building block) of this model
includes only a single infected person at the center and the
people who can contract the infection from that person
directly. In reality, the same unit cell repeats itself for
secondary, tertiary, and subsequent infections. Thus, like a
growing crystal in a crystallization process, the infection keeps
spreading within a population by repeating the unit-cell of
infection following the same probability distribution function
(equation 1).
The total number of infection (ğ¼0 ) within a unit-cell can be
estimated as (total area under the curve in figure 1a):
âˆ

ğ¼0 = âˆ«0 ğ‘ƒ(ğ‘›)ğ‘‘ğ‘›

(2).

However, in an actual scenario, only a defined number of
individuals can be detected by testing. Thus, the number of

medRxiv preprint doi: https://doi.org/10.1101/2020.05.17.20104554; this version posted May 24, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

b
% Positive in Population

Testing Rate
5

4

I = I0 (1-exp(-ln))

3

l = .03 (from the fitting)
I0 = % of population infected

2

Detection Rate

a

1

I0 = 2% of the Population (country#1)
I0 = 5% of the Population (country#2)
0
0

20

40

60

80

100

120

140

160

180

200

Average number of tests per cases (n)

Figure 1: The mathematical model of COVID-19 detection. (a) A probability function of infection transmission from a single
infected individual. The function can also indicate the probability of finding the nth person COVID-19 positive while contact
tracing. The area under the curve represents the total number of infected persons. The shaded area indicates the detected fraction
of the population when only n number of contacts are tested for the disease. (b) Detection rate as a function of the testing rate in
a population. The detected % positive rate initially increases with increasing testing rate but eventually saturates to the true % of
infection within the population.

detected (ğ¼) infection within a unit-cell can be estimated as
(shaded area under the curve in figure 1a):
ğ‘›

ğ¼ = âˆ«0 ğ‘ƒ(ğ‘›)ğ‘‘ğ‘›

(3);

where ğ‘› is the number of individuals tested per detected case
through contact tracing, a number which widely varies across
countries. The value ğ¼ is equal to the area under the curve as
illustrated in figure 1. The mathematical expression of ğ¼ can be
derived as a function of ğ‘› by solving equations 1-3. Therefore,
the detection efficiency (Ğ¤) can be estimated as the ratio of
the detected number to the actual number of infection within
the unit cell:
Ğ¤=

ğ¼
ğ¼0

If ğ· is the number of deaths from the infection within the unitcell, then the actual CFR (Î´0 ) and observed CFR (Î´) can be
defined as:
Î´0 =

ğ·

ğ·

Î´=
ğ¼
respectively.

(6)

Solving equation 1-6, the following relation can be established
between the observed case fatality (dependent variable) and
the number of testing performed per detected case
(independent variable):

(4).

It is important to note that this ratio is dimensionless and
independent of the total number of population in a region. In
other words, this relationship is not limited to the unit-cell
but applies to the whole population. Therefore the detection
rate of COVID-19 within a population can be modeled using
the relation given in equation 4. The simulated curve in figure
1b illustrates that at a given time in a region, the % detection
of infected individuals increases when the testing rate is
increased (see supplementary note Q2), but eventually
saturates when most of the infected people are already
detected within that population (Ğ¤ â‰ƒ 1). The numerical value
of exponential decay constant (ğœ† = .03) was derived from
fitting a dataset, which will be discussed later.

(5), and

ğ¼0

Î´(n) =

Î´0

(7)

1âˆ’ğ‘’ âˆ’ğœ†ğ‘›

The uncertainty of the above function (ğ›¥Î´) can be determined
using the propagation of uncertainty from ğ¼ as follows:
ğ›¥Î´
Î´

=

ğ›¥ğ¼

(8)

ğ¼

Where ğ›¥ğ¼ is the uncertainty of ğ¼ and can be calculated from
equations 1 and 3.
1

ğ›¥ğ¼ = |ğ¼(ğ‘› + ğ›¥ğ‘›) âˆ’ ğ¼(ğ‘›)| = ğ‘’ âˆ’ğœ†ğ‘› (1 âˆ’ ğ‘’ âˆ’ğœ†ğ›¥ğ‘› )
ğœ†

(9)

Solving equation 7-9, the uncertainty of observed CFR is found
to be

medRxiv preprint doi: https://doi.org/10.1101/2020.05.17.20104554; this version posted May 24, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

ğ›¥Î´(ğ‘›, ğ›¥ğ‘›) = Î´0 âŒŠ

ğ‘’ âˆ’ğœ†ğ‘›
2

(1âˆ’ğ‘’ âˆ’ğœ†ğ‘› )

ğ›¥Î´(ğ‘›, ğ›¥ğ‘›) = (ğ›¥ğ‘›)ğœ†Î´0 âŒŠ

âŒ‹ (1 âˆ’ ğ‘’ âˆ’ğœ†ğ›¥ğ‘› )

ğ‘’ âˆ’ğœ†ğ‘›
2

(1âˆ’ğ‘’ âˆ’ğœ†ğ‘› )

âŒ‹

(10)

Or,

(11),

with

above. Conceptually, countries, where a large fraction of the
screened people have been found to be contracted with the
disease (SARS-CoV-2 positive), may have insufficient data to
accurately calculate their fatality rate. The observed fatality
rates in such countries could be overestimations and may fall
within a broad range as well. In contrast, countries that have
found most of the screened suspects to be negative for the
disease (SARS-CoV-2 negative) have higher odds of
converging into the accurate estimation of the fatality rate.
The fitted value of Î´0 suggest that the true case fatality of
COVID-19 mathematically converges to 0.8% (Î´0 = 0.8 Â± 0.6)
with relatively small uncertainty (Figure 2b). This numerical
value is very similar to the fatality rate among the individuals
in the Diamond Princess cruise ship (0.99%), a unique case
study that might have provided us a reliable estimation of the
CFR of COVID-19 (2).

approximation (Taylor expansion).
Similar to detection efficiency, the equation 7-9 also holds for
the whole population outside the unit-cell. To test these
correlations within the existing datasets of COVID-19
pandemic, it is hypothesized that the actual or true fatality
rate of COVID-19 is consistent (Î´0 is a constant) worldwide.
The values of Î´(n) (total deaths/total cases) and n (total
tests/total cases) were calculated for 46 different countries
(Table S1, data collected from worldometers.info). The Î´(n) vs
ğ‘› plot was fitted using equation 7 to determine the value of Î´0 .
The fitting and the relative location of some countries are
illustrated in Figure 2. The residual analysis is shown in the
supplementary information (Figure S1). The goodness of fit
can be further improved by excluding a few countries like
Brazil and Italy who appear to be the outliers in the plot. Yet,
the hypothesis can be tested keeping the uncertainties in
mind.

It must be mentioned here that the presence of outliers in
equation 7 is plausible with a low testing ratio (ğ‘›), as the cause
of death may depend on a large number of parameters as
mentioned before. Hence, the fatality rate may not be exactly
the same for each and every country. For instance, the
observed fatality rate of Italy would be expected around 5%
from equation 7, but it is >12% in practice due to several other
factors. In contrast, the observed fatality is lower than
expected in Brazil. Although these variations are expected
from the uncertainty equations, the accurate values for
individual countries cannot be estimated using this model.

According to equation 10, the uncertainty ğ›¥Î´ linearly increases
with the value of ğ›¥ğ‘›, and decays exponentially as a function of
ğ‘›. The uncertainty regions are illustrated in Figure 2b for three
different values of ğ›¥ğ‘›. The uncertainty analysis provides
substantial supporting evidence to the hypothesis stated

a

b

Observed case fatality (%)

Raw Data

12

fitting with d = d0/(1-e-ln)

Spain

10

Î´^0

NL

8

99% confidence band

Sweden

France

6
4

Iran
India

USA

2 Brazil

South Korea
HK

Germany

Observed case fatality (%)

Belgium UK Italy
Raw data
d (n)
d (n) Â± Dd (n,Dn); Dn=1
d (n) Â± Dd (n,Dn); Dn=5
d (n) Â± Dd (n,Dn); Dn=10

14
12
10
8
6
4
2
0

0
10

Singapore

100

Number of tests per detected case (n)

10

100

Number of tests per detected case (n)

Figure 2. Correlation between the observed fatality rate and the average number of tests performed per detected case obtained
from 46 countries. (a) The fitted line (red) represents the exponential relation stated in equation 7. The shaded area is the region
of 99% confidence. Positions of several countries are indicated by arrows. (b) The regions of uncertainty (shaded area) of the
observed case fatality (red line) exponentially reduce according to equation 11. The data points tend to converge to a fixed value
of fatality rate with reduced uncertainty at a very high value of n.

medRxiv preprint doi: https://doi.org/10.1101/2020.05.17.20104554; this version posted May 24, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

An important question, which should arise in this context is
whether the CFR reflects the true severity of the disease. As
there is a time-lag between recovery and death, the CRF may
keep changing throughout the epidemic in each country and
saturate to a certain value at the end. Additional
considerations might be needed to account for the time delay
between disease onset and death (or recovery) from COVID19 infection for the assessment of the actual clinical severity of
the disease. For that, one can also look at the fatality rate in
closed cases (CCFR), which takes the relative speed between
death and recovery into considerations. At a given time point
CCFR is generally found to be higher than CRF due to the long
time delay between infection and recovery (figure 3a,
supplementary information figure S2). A fitting of CCFR with
a similar method results in a global fatality rate of around 3%
(Î´0 = 2.7 Â± 0.3). The CCFR is expected to gradually decrease
and converge to the same value of CFR at the end of the
pandemic. Thus, at any time point, both of these timesensitive indices may inaccurately represent the clinical
severity. Yet, they provide a reliable window for the true
fatality range which gradually diminishes with the duration of
the pandemic (figure 3b). This range of uncertainty would
gradually reduce with time as the pandemic progresses.

b
Fitting

Raw data,

Fitting

25

20

20

15

15

10

10

5

5

0

0
10

100

Number of tests per detected cases (n)

100

Estimated Fatality Rate (%)

Observed case fatality (%)

Raw data,

25

Observed fatality in closed cases (%)

a

One corollary which immediately manifests from this
hypothesis is a possible route of estimation of the actual size
of the outbreak. If it is assumed that most of the undetected
patients recover from a mild or asymptomatic infection, then
the current observed rate of recovery would also be an
underestimation. According to the model discussed above, the
outbreak size can be approximately estimated as a function of
ğ‘› using equation 1-4 (Figure 1b) and the fitted value of ğœ†
ğ‘‡ğ‘œğ‘¡ğ‘ğ‘™ ğ‘¡ğ‘’ğ‘ ğ‘¡ğ‘  ğ‘ğ‘’ğ‘Ÿğ‘“ğ‘œğ‘Ÿğ‘šğ‘’ğ‘‘
(Figure 4a). Assuming ğ‘› =
, and ğœ† = 0.03,
ğ‘‡ğ‘œğ‘¡ğ‘ğ‘™ ğ‘ğ‘ğ‘ ğ‘’ğ‘  ğ‘‘ğ‘’ğ‘¡ğ‘’ğ‘ğ‘¡ğ‘’ğ‘‘
equation 4 suggests that most of the countries may have
already missed a significant portion of the infected population
who might have recovered from a milder disease (Figure 4b).
For instance, France, Brazil, Iran, and Belgium who have
reported one of the highest rates (~30-50%, nâ‰ƒ2-3) of positive
cases during Covid-19 detection, might have missed up to 7590% of the true infected population till May 3, 2020. In
contrast, Vietnam, UAE, Hong Kong, South Korea, or New
Zealand who have reported the least rate of positive cases
(~0.2-2%, nâ‰ƒ50-500) might have missed only 1-10% till May 3,
2020, according to this model. However, to estimate the
number of recovered individuals from mild infection, it might
need an in-depth formulation (Figure 4a) of the rate
equations, which is outside the scope of this letter.

10

3%

1
1%

0.1

CCFR
CFR
True fatality Range

0.01

Duration of the pandemic (t)

Figure 3. The two different types of fatality rate: Observed case fatality rate (CFR) and Observed closed-case fatality rate (CCFR)
(a) The fitted lines show the difference between CFR (black) and CCFR (red). The CRF converges to 1% and CCFR converges to
3%. (b) Schematic diagram showing how CFR gradually decreases and CCFR gradually increases during the pandemic. They
converge to the same value at the end of the pandemic. The uncertainty range for the true fatality rate is shown by the green
shaded area.

medRxiv preprint doi: https://doi.org/10.1101/2020.05.17.20104554; this version posted May 24, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

f

0

I

S

k1-d
I

1-f
R2

k2

R1

d

D

I

Undetected

Total Death = D, Total Recovery = R1+R2

% of infected population (Estimated)

b

S = Succeptible, I0 = True Infected, I = Case Detected

Detected

a

Fatality Rate = D / I = fd, Recovery Rate = (R1+R2) / I
0

0

Missed Cases

Detected Cases

100
80
60
40
20
0
10

100

Number of tests per detected case (n)

Figure 4: Detected and missed cases (a) Schematic diagram showing the true size of outbreak, recovery, and death. The proportion
of undetected cases can be estimated as a function of detection efficiency (Ğ¤). (b) The estimated percent of detected and missed
cases as a function of testing rate across 46 countries. Most of the countries may have missed a significant proportion of cases
according to the model.

So, in conclusion, the analytical approach presented in this
letter shows that the widely variable observed fatality rate is a
function of the testing rate or the average tests performed per
case (see supplementary note Q3). However, the true case
fatality rate has a fixed value between 1-3% in most of the
countries. The methodology described here could be useful to
estimate the true size of the infected population, which

otherwise largely remains unknown. The accuracy of this
simple mathematical approach can be improved further with
additional parameters in future studies. This study attempts
to reliably distill the data from various countries into a
coherent mathematical formulation to estimate the global risk
of mortality during the COVID-19 pandemic.

==========================================================================
2.

The supplementary information file contains table S1, Figure S1-2, and
supplementary notes Q1-3.

drskhan@stanford.edu

No specific funding was received for this study.

The author acknowledges Stanford University for the infrastructure
and postdoctoral support. The author would like to thank his mentor
Dr. Guillem Pratx, for providing valuable feedback on this paper. The
author also thanks Dr. Soumya Poddar, Dr. Debarati Bandyopadhyay,
and Dr. Taniya Sing for valuable discussions.

1.

D. Baud et al., Real estimates of mortality following COVID-19
infection. The Lancet infectious diseases, (2020).

D. D. Rajgor, M. H. Lee, S. Archuleta, N. Bagdasarian, S. C. Quek, The
many estimates of the COVID-19 case fatality rate. The Lancet
Infectious Diseases, (2020).
3. C. Huang et al., Clinical features of patients infected with 2019 novel
coronavirus in Wuhan, China. The Lancet 395, 497-506 (2020).
4. J. T. Wu et al., Estimating clinical severity of COVID-19 from the
transmission dynamics in Wuhan, China. Nature Medicine, 1-5 (2020).
5. S. Bialek et al., Geographic differences in COVID-19 cases, deaths, and
incidenceâ€”United States, February 12â€“April 7, 2020. (2020).
6. J. Yang et al., Prevalence of comorbidities in the novel Wuhan
coronavirus (COVID-19) infection: a systematic review and metaanalysis. International Journal of Infectious Diseases, (2020).
7. J. H. Tanne et al., Covid-19: how doctors and healthcare systems are
tackling coronavirus worldwide. Bmj 368, (2020).
8. P. Forster, L. Forster, C. Renfrew, M. Forster, Phylogenetic network
analysis of SARS-CoV-2 genomes. Proceedings of the National Academy
of Sciences, 202004999 (2020).
9. Y. Ma et al., Effects of temperature variation and humidity on the
death of COVID-19 in Wuhan, China. Science of the Total Environment,
138226 (2020).
10. B. M. Ayoub, COVID-19 vaccination clinical trials should consider
multiple doses of BCG. Die Pharmazie 75, 159 (2020).
11. S. Inui et al., Chest CT findings in cases from the cruise ship â€œDiamond
Princessâ€ with coronavirus disease 2019 (COVID-19). Radiology:
Cardiothoracic Imaging 2, e200110 (2020).
12. J. Qiu, Covert coronavirus infections could be seeding new outbreaks.
Nature, (2020).

